164 related articles for article (PubMed ID: 16145474)
21. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy.
Kaleta B; Krata N; Zagożdżon R; Mucha K
Cells; 2019 May; 8(6):. PubMed ID: 31159229
[TBL] [Abstract][Full Text] [Related]
23. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.
Xu AP; Bai J; Lü J; Liang YY; Li JG; Lai DY; Wan X; Huang HH
Chin Med J (Engl); 2007 Dec; 120(23):2124-8. PubMed ID: 18167187
[TBL] [Abstract][Full Text] [Related]
25. No association of vitamin D receptor gene BsmI polymorphisms with calcium oxalate stone formation.
Chen WC; Chen HY; Hsu CD; Wu JY; Tsai FJ
Mol Urol; 2001; 5(1):7-10. PubMed ID: 11689145
[TBL] [Abstract][Full Text] [Related]
26. Association between the T-593A and C6982T polymorphisms of the osteopontin gene and risk of developing nephrolithiasis.
Gögebakan B; Igci YZ; Arslan A; Igci M; Erturhan S; Oztuzcu S; Sen H; Demiryürek S; Arikoglu H; Cengiz B; Bayraktar R; Yurtseven C; Sarıca K; Demiryürek AT
Arch Med Res; 2010 Aug; 41(6):442-8. PubMed ID: 21044748
[TBL] [Abstract][Full Text] [Related]
27. A polymorphism of matrix Gla protein gene is associated with kidney stones.
Gao B; Yasui T; Itoh Y; Tozawa K; Hayashi Y; Kohri K
J Urol; 2007 Jun; 177(6):2361-5. PubMed ID: 17509359
[TBL] [Abstract][Full Text] [Related]
28. Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones.
Bautista DS; Denstedt J; Chambers AF; Harris JF
J Cell Biochem; 1996 Jun; 61(3):402-9. PubMed ID: 8761944
[TBL] [Abstract][Full Text] [Related]
29. Osteopontin, Bone Morphogenetic Protein-4, and Vitamin D Receptor Gene Polymorphisms in the Susceptibility and Clinical Severity of Spinal Tuberculosis.
Wang G; Xie L; Hu J; Lu H; Liu X; Cao Y; Liu B; Zhang Y; Shen X
Cell Physiol Biochem; 2017; 41(5):1881-1893. PubMed ID: 28376475
[TBL] [Abstract][Full Text] [Related]
30. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR; Shafiei N; Safarinejad S
Urolithiasis; 2013 Aug; 41(4):303-13. PubMed ID: 23784265
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
[TBL] [Abstract][Full Text] [Related]
32. Arginine form of p21 gene codon 31 is less prominent in patients with calcium oxalate stone.
Chen WC; Lu HF; Chen HY; Hsu CD; Tsai FJ
Urol Res; 2001 Apr; 29(2):94-7. PubMed ID: 11396735
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients.
Mochida S; Hashimoto M; Matsui A; Naito M; Inao M; Nagoshi S; Nagano M; Egashira T; Mishiro S; Fujiwara K
Biochem Biophys Res Commun; 2004 Jan; 313(4):1079-85. PubMed ID: 14706653
[TBL] [Abstract][Full Text] [Related]
34. The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.
Lavi H; Assayag M; Schwartz A; Arish N; Fridlender ZG; Berkman N
PLoS One; 2017; 12(3):e0171945. PubMed ID: 28253271
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin polymorphisms and disease course in multiple sclerosis.
Caillier S; Barcellos LF; Baranzini SE; Swerdlin A; Lincoln RR; Steinman L; Martin E; Haines JL; Pericak-Vance M; Hauser SL; Oksenberg JR;
Genes Immun; 2003 Jun; 4(4):312-5. PubMed ID: 12761568
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell.
Yamate T; Kohri K; Umekawa T; Iguchi M; Kurita T
J Urol; 1998 Oct; 160(4):1506-12. PubMed ID: 9751404
[TBL] [Abstract][Full Text] [Related]
37. Behçet's disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms.
Chu M; Yang P; Hou S; Li F; Chen Y; Kijlstra A
Hum Immunol; 2011 Jun; 72(6):525-9. PubMed ID: 21513757
[TBL] [Abstract][Full Text] [Related]
38. Association of osteopontin gene haplotypes with nephrolithiasis.
Gao B; Yasui T; Itoh Y; Li Z; Okada A; Tozawa K; Hayashi Y; Kohri K
Kidney Int; 2007 Sep; 72(5):592-8. PubMed ID: 17519954
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
40. Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals.
Iwasaki H; Shinohara Y; Ezura Y; Ishida R; Kodaira M; Kajita M; Nakajima T; Shiba T; Emi M
J Hum Genet; 2001; 46(9):544-6. PubMed ID: 11558904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
